Synthesis of novel (2R,4R)- and (2S,4S)-iso dideoxynucleosides with exocyclic methylene as potential antiviral agents (Q40764671)

23 September 2017

Synthesis of novel (2R,4R)- and (2S,4S)-iso dideoxynucleosides with exocyclic methylene as potential antiviral agents (English)

1 reference

23 September 2017

Su Jeong Yoo

1

1 reference

23 September 2017

Hea Ok Kim

2

1 reference

23 September 2017

Yoongho Lim

3

1 reference

23 September 2017

Jeongmin Kim

4

1 reference

23 September 2017

Lak Shin Jeong

5

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Bioorganic & Medicinal Chemistry

23 September 2017

1 reference

23 September 2017

10

1 reference

23 September 2017

1

1 reference

23 September 2017

215-226

1 reference

Synthesis and antiviral activity of novel isodideoxy nucleosides with exocyclic methylene

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Synthesis and antiviral activity of D- and L-isodideoxy nucleosides with exocyclic-methylene

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Synthesis of iso-ddA, member of a novel class of anti-HIV agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Synthesis and anti-HIV activity of isonucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Inhibition of HIV integrase by novel nucleotides bearing tricyclic bases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Asymmetric synthesis of 1,3-dioxolane-pyrimidine nucleosides and their anti-HIV activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

1,3-dioxolanylpurine nucleosides (2R,4R) and (2R,4S) with selective anti-HIV-1 activity in human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Mitsunobu Reaction of Unbiased Cyclic Allylic Alcohols

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Structure--activity relationships of 1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)pyrimidine nucleosides as anti-hepatitis B virus agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Syntheses and structure--activity relationships of novel apio and thioapio dideoxydidehydronucleosides as anti-HCMV agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

A cell culture assay for compounds which inhibit hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900266-8

7 January 2021

10.1016/S0968-0896(01)00266-8

Identifiers

DOI

1 reference

23 September 2017

1 reference